Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

DSpace Repository

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

Author: Weishaupt, Carsten; Stroelin, Anke; Kahle, Birgit; Kreuter, Alexander; Schneider, Stefan W.; Gerss, Joachim; Eveslage, Maria; Drabik, Attyla; Goerge, Tobias
Tübinger Autor(en):
Strölin, Anke
Published in: Lancet Haematology (2016), Bd. 3, H. 2, S. E72-E79
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/S2352-3026(15)00251-3
ISSN: 2352-3026
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)